{
  "analysis_mode": "HISTORICAL_ONLY",
  "symbol": "OVB.L",
  "generated_at": "2026-01-21T03:35:17.496473Z",
  "top_card": {
    "ticker": "OVB.L",
    "company_name": "Ovoca Bio plc",
    "sector": "Healthcare",
    "market_cap_gbp": 9379,
    "days_active": 374,
    "apex_score_100": 48,
    "confidence_score_100": 25,
    "ai_final_score_25": 17,
    "ai_strength": "STRONG",
    "timing_regime": "BROKEN",
    "action": "AVOID",
    "thesis_one_liner": "AVOID - BROKEN timing with 48/100 opportunity score"
  },
  "enrichment": {
    "company_info": {
      "name": "Ovoca Bio plc",
      "sector": "Healthcare",
      "industry": "Biotechnology",
      "exchange": "LSE",
      "market": "AIM",
      "currency": "GBP",
      "risk_tier": "High Risk",
      "current_market_cap": 9379,
      "current_close_price": 0.0115
    },
    "basics": {
      "ticker": "OVB.L",
      "current_price": 0.0115,
      "ath": 26.0,
      "atl": 0.0115,
      "ath_date": "2022-02-23",
      "atl_date": "2025-05-08",
      "week_52_high": 1.63,
      "week_52_low": 0.0115,
      "week_52_high_date": "2025-01-24",
      "week_52_low_date": "2025-05-08",
      "drawdown_from_ath_pct": 99.96,
      "data_start": "2020-01-02",
      "data_end": "2026-01-19",
      "total_bars": 1527
    },
    "latest_signal": {
      "date": "2025-01-10",
      "scan_date": "2026-01-14",
      "signal_type": "ULTRA CRASH BOTTOM",
      "signal_color": "RED",
      "price": 0.016,
      "drawdown_pct": 99.19,
      "ai_score": 14.0,
      "rsi": 0.0,
      "cycle_position": 0.0005,
      "holding_period_days": 374,
      "current_pnl_pct": -28.12,
      "rally_state": "accumulating",
      "distance_from_high_pct": -99.28,
      "Rally_Count": 1,
      "days_since_last_high": 8,
      "last_high_date": "2026-01-06",
      "lock_in_reached": true,
      "lock_in_date": "2025-01-13",
      "best_rally_pct": 9900.0,
      "split_affected": true,
      "split_warning": "\u26a0\ufe0f",
      "warning_message": "Signal near stock split on 2025-01-10 (1:20)"
    },
    "best_historical_signal": {
      "signal_date": "2024-04-02",
      "signal_type": "EXTREME CRASH BOTTOM",
      "signal_color": "ORANGE",
      "entry_price": 0.6,
      "peak_price": 1.98,
      "peak_date": "2024-10-21",
      "rally_pct": 230.0,
      "days_to_peak": 202,
      "ai_score": 12.0
    },
    "all_historical_signals": [
      {
        "signal_id": "OVB.L_2022-12-13",
        "signal_date": "2022-12-13",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 4.75,
        "current_price": 0.0115,
        "current_return_pct": -99.76,
        "best_rally_pct": 194.74,
        "best_rally_date": "2023-08-29",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -99.92,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 1128,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2022-12-14",
        "signal_date": "2022-12-14",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 4.75,
        "current_price": 0.0115,
        "current_return_pct": -99.76,
        "best_rally_pct": 194.74,
        "best_rally_date": "2023-08-29",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -99.92,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 1127,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-08-31",
        "signal_date": "2023-08-31",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 2.75,
        "current_price": 0.0115,
        "current_return_pct": -99.58,
        "best_rally_pct": -12.73,
        "best_rally_date": "2023-09-01",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 867,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-09-01",
        "signal_date": "2023-09-01",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 2.4,
        "current_price": 0.0115,
        "current_return_pct": -99.52,
        "best_rally_pct": -6.25,
        "best_rally_date": "2023-09-04",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 866,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-09-06",
        "signal_date": "2023-09-06",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 2.25,
        "current_price": 0.0115,
        "current_return_pct": -99.49,
        "best_rally_pct": -4.44,
        "best_rally_date": "2023-09-07",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 861,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-10-05",
        "signal_date": "2023-10-05",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 1.4,
        "current_price": 0.0115,
        "current_return_pct": -99.18,
        "best_rally_pct": 37.14,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 832,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-10-06",
        "signal_date": "2023-10-06",
        "signal_type": "ENHANCED CRASH CRASH-ACCUM COMBO",
        "signal_color": "PURPLE",
        "entry_price": 1.475,
        "current_price": 0.0115,
        "current_return_pct": -99.22,
        "best_rally_pct": 30.17,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 831,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-10-10",
        "signal_date": "2023-10-10",
        "signal_type": "ENHANCED EXTREME CRASH-ACCUM COMBO",
        "signal_color": "PURPLE",
        "entry_price": 1.3,
        "current_price": 0.0115,
        "current_return_pct": -99.12,
        "best_rally_pct": 47.69,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 827,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-10-13",
        "signal_date": "2023-10-13",
        "signal_type": "ENHANCED CRASH CRASH-ACCUM COMBO",
        "signal_color": "PURPLE",
        "entry_price": 1.3,
        "current_price": 0.0115,
        "current_return_pct": -99.12,
        "best_rally_pct": 47.69,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 824,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-11-29",
        "signal_date": "2023-11-29",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 1.25,
        "current_price": 0.0115,
        "current_return_pct": -99.08,
        "best_rally_pct": 53.6,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 777,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-12-01",
        "signal_date": "2023-12-01",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 1.15,
        "current_price": 0.0115,
        "current_return_pct": -99.0,
        "best_rally_pct": 66.96,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 775,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-12-05",
        "signal_date": "2023-12-05",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 1.15,
        "current_price": 0.0115,
        "current_return_pct": -99.0,
        "best_rally_pct": 66.96,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 771,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-12-07",
        "signal_date": "2023-12-07",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 1.05,
        "current_price": 0.0115,
        "current_return_pct": -98.9,
        "best_rally_pct": 82.86,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 4,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 769,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-12-21",
        "signal_date": "2023-12-21",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.9,
        "current_price": 0.0115,
        "current_return_pct": -98.72,
        "best_rally_pct": 113.33,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 4,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 755,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-12-22",
        "signal_date": "2023-12-22",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 0.9,
        "current_price": 0.0115,
        "current_return_pct": -98.72,
        "best_rally_pct": 113.33,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 4,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 754,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-12-27",
        "signal_date": "2023-12-27",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.9,
        "current_price": 0.0115,
        "current_return_pct": -98.72,
        "best_rally_pct": 113.33,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 4,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 749,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2024-01-04",
        "signal_date": "2024-01-04",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 0.825,
        "current_price": 0.0115,
        "current_return_pct": -98.61,
        "best_rally_pct": 132.73,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 5,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 741,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2024-02-29",
        "signal_date": "2024-02-29",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.8,
        "current_price": 0.0115,
        "current_return_pct": -98.56,
        "best_rally_pct": 140.0,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 5,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 685,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2024-03-26",
        "signal_date": "2024-03-26",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 0.7,
        "current_price": 0.0115,
        "current_return_pct": -98.36,
        "best_rally_pct": 174.29,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 659,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2024-04-02",
        "signal_date": "2024-04-02",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 0.6,
        "current_price": 0.0115,
        "current_return_pct": -98.08,
        "best_rally_pct": 220.0,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 652,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2024-04-03",
        "signal_date": "2024-04-03",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.6,
        "current_price": 0.0115,
        "current_return_pct": -98.08,
        "best_rally_pct": 220.0,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 651,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2024-07-01",
        "signal_date": "2024-07-01",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 0.775,
        "current_price": 0.0115,
        "current_return_pct": -98.52,
        "best_rally_pct": 147.74,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 562,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2024-08-28",
        "signal_date": "2024-08-28",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 0.725,
        "current_price": 0.0115,
        "current_return_pct": -98.41,
        "best_rally_pct": 164.83,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 504,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2025-01-10",
        "signal_date": "2025-01-10",
        "signal_type": "ULTRA CRASH BOTTOM",
        "signal_color": "RED",
        "entry_price": 0.016,
        "current_price": 0.0115,
        "current_return_pct": -28.12,
        "best_rally_pct": 9900.0,
        "best_rally_date": "2025-01-13",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -99.28,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 369,
        "status": "historical"
      }
    ],
    "stats": {
      "total_signals": 24,
      "win_rate_pct": 95.8,
      "avg_rally_pct": 537.01,
      "median_rally_pct": 120.0,
      "best_rally_pct": 10362.5,
      "worst_rally_pct": -3.27
    },
    "splits": [
      {
        "date": "2025-01-10",
        "ratio": "1:20",
        "ratio_value": 100.0
      },
      {
        "date": "2025-05-08",
        "ratio": "1:20",
        "ratio_value": 100.0
      }
    ],
    "split_risk": {
      "split_detected": false,
      "risk_level": "NONE",
      "confidence": "HIGH"
    },
    "data_quality": {
      "price_reliability": "SUSPECT",
      "pnl_reliability": "SUSPECT",
      "overall_confidence": "LOW"
    },
    "risk_flags": [
      "SIGNAL_NEAR_SPLIT",
      "HAS_REVERSE_SPLIT",
      "EXTREME_DRAWDOWN",
      "FREQUENT_CRASHES"
    ],
    "last_updated": "2026-01-20 22:09:53 UTC",
    "volatility": {
      "atr_normalized": 10.0,
      "stddev_20d": 0.0
    },
    "trends": {
      "intelligence_signal": "ACCUMULATION"
    }
  },
  "decision_summary": {
    "why_it_matters": [
      "APEX 48/100 indicates moderate opportunity quality",
      "Timing regime: BROKEN",
      "Historical profile: 1 rallies, 9900% best run"
    ],
    "main_risk": "Confidence 25/100 - full data loaded",
    "watch_next": [
      "RNS catalysts (funding/operational updates)",
      "Volume expansion confirmation",
      "Timing regime change signals"
    ]
  },
  "triangulation": {
    "rns": {
      "has_data": true,
      "ticker": "OVB.L",
      "latest": [
        {
          "title": "Schedule One - Ovoca Bio Plc",
          "announcement_date": "31st Dec 2025",
          "release_time": "8:00 am",
          "source": "RNS",
          "content": "31 Dec 2025 08:00\nRNS Number : 2768N\nAIM\n31 December 2025\nANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES (\"AIM RULES\")\nCOMPANY NAME:\nOvoca Bio Plc (\"Ovoca\") to be renamed\nTalisman Metals plc\non Admission (\"Talisman\" or the \"Company\")\nCOMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING ADDRESS (INCLUDING POSTCODES):\n17 Pembroke Street Upper\nDublin 2\nD02 AT22\nIreland\nCOUNTRY OF INCORPORATION:\nIreland\nCOMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY AIM RULE 26:\nhttps://www.ovocabioplc.com\nto be\nwww.talismanmetalsplc.com\nafter re-Admission\nCOMPANY BUSINESS (INCLUDING\nMAIN COUNTRY OF OPERATION\n) OR, IN THE CASE OF AN\nINVESTING COMPANY\n, DETAILS OF ITS\nINVESTING POLICY\n). IF THE\nADMISSION\nIS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED:\nOn 7 May 2025, Ovoca announced it had entered into a conditional Letter of Intent (\"\nLOI\n\") to acquire 100% of Tadeen, a UK-registered company, which indirectly owns 100% of the Licences in Morocco, prospective for Copper and Silver (the \"\nAcquisition\n\"), through its wholly owned subsidiary, Horizons Mines SARL.\nTadeen was incorporated in 2021 and since that time has sought to develop and subsequently commercialise mineral exploration and exploitation properties with strong geological potential in the promising jurisdiction of Morocco. The Company will only focus its work on 10 of the exploration permits, five comprising the\nTizert Project\nand five making up the\nArgana Project\n, with a total combined area of 129.8km2 (together the \"\nExploration Permits\n\" for the purposes of this Document). These are between 8 and 30km from the large Tizert Copper-Silver Project being developed by the Managem SA Group (Managem) the Moroccan listed Mining Group for which the Government owns a majority stake. On completion of the Transaction, various members of the senior management team of Tadeen will be integrated into the Enlarged Group. The existing Chief Executive Officer of Ovoca, Timothy McCutcheon, will serve as Chief Executive Officer of the Enlarged Group.\nThe Transaction constitutes a reverse takeover under AIM Rule 14, requiring the approval of a majority of the Shareholders voting in person or by proxy at a general meeting\nOn Admission, Talisman Metals plc will, through its wholly owned Bermudan subsidiary T Metals Limited, will own 100% of Tadeen (the acquisition target) which in turn holds 100% of Horizons Mines SARL who own the Exploration Permits.\nDETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY\nRESTRICTIONS AS TO TRANSFER\nOF THE SECURITIES (i.e. where known, number and type of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares):\nNumber of ordinary shares of \u20ac0.02 each (\"Ordinary Shares\") for which Admission is being sought: 64,174,918\nThe Ordinary Shares are and will remain freely transferable and have no restrictions as to transfer placed on them.\nThe issue price: 7.7 pence (the \"Issue Price\").\nNo Shares are or will be held in treasury.\nCAPITAL TO BE RAISED ON ADMISSION (AND/OR SECONDARY OFFERING) AND ANTICIPATED MARKET CAPITALISATION ON ADMISSION:\nCapital to be raised on Admission: \u00a31.155 million\nAnticipated market capitalisation on Admission: approximately \u00a34.9 million (at the Issue Price)\nPERCENTAGE OF AIM SECURITIES\nNOT IN PUBLIC HANDS AT ADMISSION\n:\n39.01%\nDETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM\nTO WHICH THE AIM SECURITIES (OR OTHER SECURITIES OF THE COMPANY) ARE OR WILL BE ADMITTED OR TRADED:\nN/A\nTHE COMPANY HAS APPLIED FOR THE\nVOLUNTARY CARBON MARKET DESIGNATION\n(Y/N)\nNo\nFULL NAMES AND FUNCTIONS OF\nDIRECTORS\nAND PROPOSED DIRECTORS (underlining the first name by which each is known or including any other name by which each is known):\nTimothy (\"\nTim\n\") Rand McCutcheon - Chief Executive Officer\nLeah\nEllen O'Donovan - Chief Financial Officer\nJonathan\nGeorge Henry - Independent Non-Executive Chair\nAnastasia\nLevashova - Independent Non-Executive Director\nThomas (\"T\nom\n\") Alan Garagan - Independent Non-Executive Director\nDr\nMohammed\nMouhib - Non-Executive Director\nFULL NAMES AND HOLDINGS OF\nSIGNIFICANT SHAREHOLDERS\nEXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER ADMISSION (underlining the first name by which each is known or including any other name by which each is known):\nName\nNumber of Ordinary Shares before Admission\nPercentage of\nExisting\nOrdinary Shares\nNumber of Ordinary Shares on Admission**\nPercentage\nof\nEnlarged\nShare\nCapital\nEuoclear Nominees Limited*\n67,913,860\n76.77%\n22,637,953\n35.28%\nTimothy McCutheon (CEO)*\n19,506,203\n22.05%\n6,679,613\n10.41%\nPicko Trading Co Limited\n10,002,077\n11.31%\n3,334,026\n5.20%\nNational Settlement Depository*\n9,893,214\n11.18%\n3,297,738\n5.14%\nInvestor Services Nominees Limited*\n4,158,532\n4.70%\n1,386,177\n2.16%\nCambrian Limited\n-\n-\n6,252,049\n9.74%\nCharterhouse Trustees Limited\n-\n-\n6,252,049\n9.74%\nAya Silver & Gold Inc.\n-\n-\n3,000,000\n4.67%\nZakariae Mouhib\n-\n-\n2,925,610\n4.56%\nMohamed Baoutoul\n-\n-\n2,925,610\n4.56%\n* All of these shares are held through Euroclear Nominees Limited\n** Following a 3:1 share consolidation\nNAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:\nNone\n(i) ANTICIPATED ACCOUNTING REFERENCE DATE\n(ii) DATE TO WHICH THE\nMAIN FINANCIAL INFORMATION\nIN THE ADMISSION DOCUMENT HAS BEEN PREPARED (this may be represented by unaudited interim financial information)\n(iii) DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS PURSUANT TO AIM RULES 18 AND 19:\n(i) 31 December\n(ii) 30 June 2025\n(iii) As follows:\n-\n30 June 2026 (audited accounts for the year ended 31 December 2025)\n-\n30 September 2026 (unaudited interim financial statements for 6 months ended 30 June 2026)\n-\n30 June 2027 (audited accounts for the year ended 31 December 2026)\nEXPECTED ADMISSION DATE:\n28 January 2026\nNAME AND ADDRESS OF NOMINATED ADVISER:\nBeaumont Cornish Limited\n5-10 Bolton Street\nLondon\nW1J 8BA\nNAME AND ADDRESS OF BROKER:\nCMC Markets UK plc\n133 Houndsditch\nLondon\nEC3A 7BX\nOTHER THAN IN THE CASE OF A\nQUOTED APPLICANT\n, DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:\nThe AIM Admission Document, which will contain full details of the applicant and admission of its securities, will be available from the Company's website:\nhttps://www.ovocabioplc.com\nto be\nwww.talismanmetalsplc.com\nafter re-Admission\nTHE CORPORATE GOVERNANCE CODE THE APPLICANT HAS DECIDED TO APPLY\nQCA Code\nDATE OF NOTIFICATION:\n31 December 2025\nNEW/ UPDATE:\nNew\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nPAAPKDBPABDKBBN",
          "rns_number": "RNS Number : 2768N"
        },
        {
          "title": "Notice of AGM",
          "announcement_date": "31st Dec 2025",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "31 Dec 2025 07:00\nRNS Number : 2044N\nOvoca Bio PLC\n31 December 2025\nOvoca Bio PLC\n31 December 2025\nOvoca Bio plc\n(\"Ovoca\" or the \"Company\")\nNotice of AGM\nDublin, Ireland, December 31, 2025 - Ovoca Bio announces that its Notice of Annual General Meeting (\"AGM\"), containing details of the resolutions to be proposed at the AGM, has been published and is being posted to Shareholders. The Notice of AGM is also available on the Company's website at\nwww.ovocabio.com\nThe Company's 2025 AGM will be held at The Mespil Hotel, 50-60 Mespil Road, Dublin 4, D04 E7N2, Ireland on January 27, 2026 at 10:30 a.m. Further details in relation to shareholder participation in the meeting is detailed in the Notice of AGM.\nEnd\nFor further information:\nOvoca Bio plc\nTim McCutcheon (Chief Executive Officer)\nTel +353 1 661 9819\ninfo@ovocabio.com\nBeaumont Cornish Limited (Nominated Adviser)\nJames Biddle / Roland Cornish\nTel: +44 (0) 207 628 3396\nCMC Markets UK Plc (Broker)\nThomas Smith / Thomas Curran\nTel: +44 (0) 20 3003 8632\nNominated Adviser Statement\nBeaumont Cornish Limited (\"Beaumont Cornish\"), is the Company's Nominated Adviser and is authorised and regulated in the United Kingdom by the Financial Conduct Authority. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other person for providing the protections afforded to customers of Beaumont Cornish nor for advising them in relation to the transaction and arrangements described in the announcement or any matter referred to in it.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nNOABCBDDCBXDGUG",
          "rns_number": "RNS Number : 2044N"
        },
        {
          "title": "Publication of Admission Document",
          "announcement_date": "31st Dec 2025",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "31 Dec 2025 07:00\nRNS Number : 2066N\nOvoca Bio PLC\n31 December 2025\nTHIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE, TRANSMISSION, DISTRIBUTION OR FORWARDING, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM\u00a0THE UNITED STATES,\u00a0AUSTRALIA,\u00a0CANADA,\u00a0JAPAN\u00a0OR THE\u00a0REPUBLIC OF SOUTH AFRICA\u00a0OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE, TRANSMISSION, DISTRIBUTION OR FORWARDING WOULD BE UNLAWFUL (OR TO ANY PERSONS IN ANY OF THOSE JURISDICTIONS).\nTHIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY PERSON TO PURCHASE AND/OR SUBSCRIBE FOR, OTHERWISE ACQUIRE OR DISPOSE OF ANY SECURITIES IN OVOCA BIO PLC OR ANY OTHER ENTITY IN ANY JURISDICTION. NEITHER THIS ANNOUNCEMENT NOR THE FACT OF ITS DISTRIBUTION, SHALL FORM THE BASIS OF, OR BE RELIED ON IN CONNECTION WITH ANY INVESTMENT DECISION IN RESPECT OF OVOCA BIO PLC.\nTHIS ANNOUNCEMENT CONTAINS INSIDE\nINFORMATION\nPURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU WHICH IS PART OF DOMESTIC LAW IN THE UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND (\"UK\") PURSUANT TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS (\nSI 2019/310\n) (\"UK MAR\"). IN ADDITION, MARKET SOUNDINGS (AS DEFINED IN UK MAR) WERE TAKEN IN RESPECT OF CERTAIN OF THE MATTERS CONTAINED WITHIN THIS ANNOUNCEMENT, WITH THE RESULT THAT CERTAIN PERSONS BECAME AWARE OF INSIDE INFORMATION (AS DEFINED UNDER UK MAR). UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THOSE PERSONS THAT RECEIVED INSIDE INFORMATION IN A MARKET SOUNDING ARE NO LONGER IN POSSESSION OF SUCH INSIDE INFORMATION, WHICH IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.\n31 December 2025\nOvoca Bio plc (to be renamed\nTalisman Metals plc\non Admission)\n(\"\nOvoca\n\", \"Talisman\" or the \"Company\")\nProposed acquisition of up to 100 per cent. of Tadeen International Limited\nChange of name to\nTalisman Metals plc\nFundraising, Share Capital Reorganisation\nAdmission of the Enlarged Group to trading on AIM\nNotice of Extraordinary General Meeting\nand\nPublication of Admission Document\nOvoca Bio plc (to be renamed\nTalisman Metals plc\non Admission\n)\nis pleased to announce that, further to the announcement of 7 May 2025, it has now entered into a Share Purchase Agreement to acquire up to 100 per cent of the share capital of Tadeen International Limited in consideration for the allotment for Consideration Shares to the Sellers.\nAt the same time as the acquisition announcement, Ovoca announced that it had sold its wholly-owned subsidiary Silver Star, which owned 100% of IVIX LLC, thereby, given the Board's recent decision to allow the Orenetide and related patents to lapse, completely exiting the biopharmaceutical business, which had been its core business. The Company therefore, in ceasing any of its former biopharmaceutical development activities and retaining no biopharmaceutical intellectual property, became an AIM Rule 15 cash shell on that date.\nThe Proposed Acquisition constitutes a reverse takeover under the AIM Rules for Companies (the \"\nAIM Rules\n\") as,\ninter alia\n, the Proposed Acquisition will fundamentally change the Company into an operating mining exploration business and therefore, in accordance with Rule 14 of the AIM Rules, application will be made for the enlarged share capital to be readmitted to AIM.\nTadeen is a UK company focused, through its wholly-owned subsidiary Horizons Mines SARL (who owns the permits), on the development of a portfolio of mineral exploration licences, with a primary focus on copper mineralisation, within Morocco. Tadeen was incorporated in 2021 and since that time has sought to develop and subsequently commercialise mineral exploration and exploitation properties with strong geological potential in the promising jurisdiction of Morocco. The Company will only focus its work on 10 of the exploration permits, five comprising the\nTizert Project\nand five making up the\nArgana Project\n, with a total combined area of 129.8km2 (together the \"Exploration Permits\" for the purposes of the Admission Document).\nThe nature of the Company's business will be transformed by the Transaction and, in order to reflect its new activities, it is proposed to change the Company's name to Talisman Metals plc, subject to the approval of the Shareholders and Irish Companies Registration Office (\"CRO\").\nIn connection with the Proposed Acquisition the Company will be issuing Consideration Shares, Novation Shares, Tadeen Creditor Shares and Fundraising Shares. Additionally, the Company is proposing a 3:1 consolidation whereby every 3 Existing Ordinary Shares will be exchanged for 1 New Ordinary Share, resulting in a nominal value of New Ordinary Shares of \u20ac0.02 each subsequent to the Share Consolidation.\nAt the same time, the Company has completed the Fundraising to raise a gross amount of \u00a31,155,000 at a price of 7.7 pence per New Ordinary Share to fund, along with its existing cash resources, the work programme on the Core Exploration Permits, provide general working capital and fund the costs of Admission.\nI\nn the opinion of the Existing Directors, the acquisition of Tadeen is an attractive opportunity for the Company. The development of promising mineral properties, focused on Copper, a commodity that enjoys strong future growth fundamentals, in a country that is well endowed geologically and has a strong, and investor-friendly legal framework for mineral development activities. Provides an attractive opportunity that the Existing Directors believe, has the potential to generate significant shareholder value.\nUpon completion of the Proposed Transaction, the Company will trade under the new name of \"Talisman Metals plc\" and its new TIDM will be \"TLM\".\nBeaumont Cornish Limited (\"\nBeaumont Cornish\n\") is the Nominated Adviser and CMC Markets UK plc is acting as Broker to the Company.\nThe Admission Document is being posted to Shareholder and will shortly be available on the Company's website at\nhttps://ovocabio.com\n. Trading in the Company's Ordinary Shares on AIM remains suspended pending approval by Shareholders at the EGM for the Transaction.\nOvoca Bio has published an Admission Document in order to seek shareholder approval for the Proposed Acquisition and associated resolutions. Extracts from the Admission Document including a Timetable and Placing Statistics are included as an Appendix to this announcement. At the same time the Company has published a Notice of EGM\nto be held at\nThe Mespil Hotel, 50-60 Mespil Road, Dublin 4, D04 E7N2, Ireland on 27 January 2026 at 11.00 a.m.\n(or, if later, as soon as practicable after the Extraordinary General Meeting shall have been concluded or adjourned), notice of which is set out at the end of the Admission Document.\nTimothy McCutcheon, CEO of Ovoca Bio, said:\n\"I want to congratulate the entire team of employees, counterparties, consultants and advisors on getting this transaction through the process of readmission to AIM. Morocco is a great place to work for natural resources, copper is a great focus point given that metal is presently trading at all-time highs, and exploration work has never been more needed for a growing world that is far behind in identifying new sources of raw materials to support future plans. We move onward to the EGM, and as the largest single shareholder of Ovoca, I am confident the transaction will close smoothly and we can immediately shift to working in the field to add shareholder value via geological work.\"\nCapitalised terms used in this announcement shall, unless otherwise defined, have the same meanings as set out in the Admission Document. Shareholders are strongly encouraged to read the Admission Document in full as part of their voting consideration at the General Meeting.\nFor the purposes of UK MAR, the person responsible for arranging release of this Announcement on behalf of the Company is Timothy McCutcheon, CEO.\nEnquiries:\nOvoca Bio plc\nTimothy\nMcCutcheon\n, CEO\ninfo@ovocabio.com\nTel: +353 1 661 9819\nNominated Adviser\nBeaumont Cornish Limited\nRoland Cornish\nJames Biddle\nTel: +44 (0) 20 7628 3396\nBroker\nCMC Markets UK plc\nThomas Smith / Thomas Curran\nTel: +44 (0) 20 3003 8255\nBeaumont Cornish, which is authorised and regulated in the United Kingdom by the FCA, is acting exclusively for the Company as Nomad in connection with the Admission and is not acting for any other person (including a recipient of this document) or otherwise be responsible to any person for providing the protections afforded to clients of Beaumont Cornish or for advising any other person in respect of the Admission or any transaction, matter or arrangement referred to in this document. The responsibility of Beaumont Cornish, as the Nomad, under the AIM Rules for Nominated Advisers is owed solely to the London Stock Exchange and is not owed to the Company or the Directors or any other person.\nCMC Markets UK plc (\"CMC\"), which is authorised and regulated in the United Kingdom by the FCA, is acting exclusively for the Company as its Broker in connection with the Proposed Placing and Admission and is not acting for any other person (including a recipient of this document) or otherwise be responsible to any person for providing the protections afforded to clients of CMC} or for advising any other person in respect of the Proposed Placing and Admission or any transaction, matter or arrangement referred to in this document.\nNo representation or warranty, express or implied, is made by Beaumont Cornish, CMC or any of their respective Representatives as to the contents of this document (without limiting the statutory rights of any person to whom this document is issued). No liability whatsoever is accepted by Beaumont Cornish, CMC or any of respective Representatives for the accuracy of any information or opinions contained in this document or for the omission of any material information for which it is not responsible. The information contained in this document is not intended to inform or be relied upon by any subsequent purchasers of Ordinary Shares (whether on or off exchange) and accordingly, to the extent permitted by law, no duty of care is accepted by the Company, Beaumont Cornish or CMC} in relation to any of them.\nThis announcement includes statements that are, or may be deemed to be, \"forward-looking statements\". These forward-looking statements relate to, inter alia, analyses and other information that are based on forecasts of future results, estimates of amounts not yet determinable and the Enlarged Group's future prospects, developments and business strategies.\nThese forward-looking statements can be identified by their use of terms and phrases such as \"anticipate\", \"believe\", \"could\", \"estimate\", \"expect\", \"intend\", \"may\", \"plan\", \"predict\", \"project\", \"will\" or the negative of those variations, or comparable expressions, including references to assumptions. These forward-looking statements are primarily contained in Part I - Letter from the CEO of the Admission Document but may also appear elsewhere throughout it.\nThe forward-looking statements in the Admission Document, including statements concerning projections of the Enlarged Group's future results, operations, profits and earnings, are based on current expectations and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by those forward-looking statements.\nCertain risks to and uncertainties for the Enlarged Group are specifically described in the risk factors set out in Part 2 - Risk Factors of the Admission Document. If one or more of these risks or uncertainties materialises, or if underlying assumptions prove incorrect, the Enlarged Group's actual results may vary materially from those expected, estimated or projected. Given these risks and uncertainties, potential investors should not place any reliance on forward-looking statements.\nForward-looking statements may and often do differ materially from actual results. Any forward-looking statements in this document are based on certain factors and assumptions, including the Directors' current views with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions relating to the Enlarged Group's operations, results of operations, growth strategy and liquidity. Whilst the Directors consider these assumptions to be reasonable based upon information currently available to them, they may prove to be incorrect. Accordingly, prospective investors are cautioned not to place undue reliance on any forward-looking statements and should specifically consider the risk factors set out in Part II - Risk Factors of the Admission Document that could cause actual results to differ before making an investment decision.\nNeither the Directors nor the Company undertake any obligation to update forward-looking statements or risk factors other than as required by the AIM Rules, UK MAR or by the rules of any other securities regulatory authority whether as a result of new information, future events or otherwise.\nAppendix 1\nBackground and history\nIn 2023 Tadeen acquired 100% of the issued share capital of Horizons, a Moroccan legal entity that owns the thirteen (13) Exploration Permits, including the 10 Core Exploration Permits, and one (1) non-core mining licence.\nThe Projects are within central Morocco, between 80km and 200km south of Marrakech (Figure 1-1), located within the Anti-Atlas and High-Atlas Mountain ranges. Topography is rugged and hilly, but the Projects are easily accessed except for the Argana project which occupies an area of steep mountain slopes. The Tizert Project includes three target areas, Tizert North, Fougnar and Tizert South. These are between 8 and 30km from the large Tizert Copper-Silver Project being developed by the Managem SA Group (Managem) the Moroccan listed Mining Group for which the Government owns a majority stake.\nThe Exploration permits\nThe Company will only focus its work on the Core Exploration Permits, five comprising the\nTizert Project\nand five making up the\nArgana Project\n, with a total combined area of 129.8km2. The CPR only describes these two Projects; given no exploration expenditure will be spent on the other permits and Mining Licence, which are considered non-core. For the avoidance of doubt Fam Al Hisn -Taghjijt/Tastifft Project, El Gloa Project and Msissi Mining Licence are all considered non-core (\"\nnon- core permits\n\").\nThe CPR includes details of the Core Exploration Permits. The first renewal period for all Argana Project Exploration Permits, and the three Exploration Permits within the Tizert Project (namely Tizert North and Tizert South as seen below) expired during September 2025 and were successfully renewed with validity for 4 years ending 5th September 2029, after which they must be converted to a full mining licence or relinquished.\nTizert Project\nAt the Fougnar and Tizert South permits, the Precambrian-to-Cambrian-aged Adoudou Formation is exposed, unconformably overlying the Precambrian basement. The lower part of the Adoudou Formation is named the 'Basal Series' and is the host to the mineralisation on the Tizert Project and at Managem's important Tizert Deposit (the 'Tizert Deposit'). On Fougnar and Tizert South permits mineralisation is in the form of malachite within greenish siltstones as scattered minor occurrences within two or possibly three stratigraphic levels within the Basal Series which typically has a dip of 15\u00b0 to 20\u00b0 to the to the west and SSE respectively.\nThe target type is Cu-Ag deposits of the Sediment- Hosted-Stratiform Copper (SHSC) type which are the world's second most important in terms of copper production4, typically comprising extensive layers with copper sulphide mineralisation that can reach tens of metres in thickness. The nearby Tizert Deposit owned by Managem is of this type. The southernmost of the Tizert North permits is approximately 8km NE from the northern limit the Tizert Deposit and potentially 'on trend' but the depth to the target Basal Series is over 300m. The Tizert Projects, particularly Fougnar will be the focus of the Issuer's immediate strategy and work programme expenditure.\nArgana Project\nThe Argana Project is in younger rocks of the Triassic aged red-bed formations which were deposited in a late Permian to Triassic rift basins. Copper and lesser Ag and uranium (U) mineralisation is found in the area hosted by 30\u00b0-40\u00b0 (mostly) northward dipping peneconcordant lenses within the middle units of the Triassic red-beds. Lenses are 10-40m in lateral extent, up to 2.5m thick and with unknown down-dip extent, well exposed on the adjacent properties, one of which is within in an excluded block within one of the permits. There are some small-scale mining activities exploiting the lenses on the adjacent properties. The mineralisation type is of the Red-bed copper which is a smaller subtype of the Sediment Hosted Copper type. Sporadic uranium mineralisation is observed at surface but the potential for more significant mineralisation of the sandstone-hosted type should be considered, as the geological setting is favourable, i.e. extensive intra-cratonic rift-controlled continental fluvial to marginal marine sediments, within an area with volcanic and other potential uranium-bearing source rocks.\nExploration work\nHorizons (\"HM\") has not completed any exploration on the Projects, the small amount of documented work was by previous explorers, mostly by the current holding company HM. There has been no drilling except for three holes completed during July 2025, one on each of the three permits forming the Tizert North and Tizert South permits. Analyses were carried out at laboratories in Morocco, mostly at the geochemical laboratory of the Office National des Hydrocarbures et des Mines (ONHYM) in Rabat or at Mining Development Analysis (ADM) laboratory in Marrakech.\nTizert Project\nOn the Tizert Projects HM has carried out geological mapping, rock and channel sampling, at the Fougnar and Tizert South permits; achieving grades mostly between 0.5 and 1.44 % Cu over intervals with length 0.5m to 1.3m from the channel samples, from mineralisation in the 'Basal Series' which is the host to most of the copper at Managem's Tizert deposit. A single drill-hole on the Tizert South permit was completed in July 2025 and intersected a minor copper bearing interval of 2m with an average of 0.27% Cu (and Ag <1.5g/t) from a depth of 99m, probably the down-dip extension of minor secondary copper minerals observed at surface. Results of the Quality Control-Quality Assurance (QA-QC) samples suggest that the aforementioned grade of this interval may have been slightly understated and may be approximately 0.3% Cu. No drilling has been carried out on the Fougnar permit even though it is the most promising of the permits comprising the Tizert Project. Two holes were drilled at the Tizert North permits were completed but need to be deepened to reach the target depth.\nArgana Project\nAt the Argana Project, HM carried out rock chip and channel sampling on the permits comprising the Project and on adjacent ground, and enclosed excluded zones (small Exploitation Licenses by other companies within HM's Exploration Permits). HM confirmed that high grade Cu mineralisation (up to 4.75% Cu) with up to 50g/t Ag is present, hosted in lenses found within the enclosed excluded zones (not part of the Project), of the 'Red-bed' Sediment-Hosted copper type. On the permit areas held by HM, some lower grade copper mineralisation has been sampled, the best being a channel sample with 0.88% Cu over 1.0m (true thickness). A surface electrical survey was completed during June 2025 aimed at identifying chargeability anomalies that may or may not indicate sulphide mineralisation; some anomalies were observed but these may be due to clay layers or groundwater. There has been no drilling at the Argana Project to date.\nDetails of the Fundraising\nThe Company has conditionally raised \u00a31,155,000 (before expenses) through the Fundraise.\nPlacing\nThe Company is proposing to issue 4,545,454 New Ordinary Shares at the Placing Price to the Placees to raise \u00a3350,000 (before expenses). The Company, the Directors, Beaumont Cornish and CMC have entered into the Placing Agreement relating to the Placing pursuant to which, subject to certain conditions, CMC has conditionally agreed to use its reasonable endeavours to procure Placees for the Placing Shares.\nThe Placing Agreement is conditional, amongst other things, upon Admission having become effective by no later than 8.00 a.m. on 28 January 2026 or such later time and date as the Company, Beaumont Cornish and CMC may agree (being not later than 8.00 a.m. on 31 January 2026). Further details of the Placing Agreement are set out in paragraph 13 (h) of Part 8 (\nAdditional Information, Material Contracts\n) of the Document.\nSubscription\nThe Company is proposing to issue 10,454,546 Subscription Shares at the Issue Price to the Subscribers to raise \u00a3805,000 (before expenses). Each of the Subscribers has entered into a Subscription Agreement with the Company pursuant to which, subject to certain conditions, they will subscribe for the Subscription Shares.\nEach Subscription Agreement is conditional, amongst other things, upon Admission having become effective by no later than 8.00 a.m. on 28 January 2026 or such later time and date as the Company, Beaumont Cornish and CMC may agree (being not later than 8.00 a.m. on 31 January 2026).\nFurther details of the Subscription Agreements are set out in paragraph 13(e) of Part 8 (\nAdditional Information, Material Contracts\n) of the Document.\nThe Placing Shares and Subscription Shares will represent approximately 23.4 per cent. of the Enlarged Share Capital.\nUse of Proceeds\nThe Company has conditionally raised Gross Proceeds of \u00a31.155m through the Fundraising, comprising Placing Proceeds of \u00a3350,000 and Subscription Proceeds of \u00a3805,000. On Admission, the Gross Proceeds will be aggregated with the Enlarged Group's existing cash resources of approximately \u00a31.155m resulting in total cash resources available to the Enlarged Group of approximately \u00a32.255m. The total cash on Admission is expected to be used to as follows:\n-\nTo settle outstanding Admission expenses of approximately \u00a3310,000;\n-\nTo fund the Phase 1 Exploration Program amounting to \u00a3322,000;\n-\nTo fund approximately 75% of Phase 2 Exploration Expenditure of approximately \u00a3400,000; and\n-\nGeneral Working Capital purposes of approximately \u00a31,200,000.\nShareholder approval\nOvoca Bio has published an Admission Document in order to seek shareholder approval for the Proposed Acquisition and associated resolutions.\nExtraordinary General Meeting and Resolutions\nSet\nout at the end of this Document is the Notice convening the Extraordinary General Meeting to be held at\nBuswells Hotel, 23-27 Molesworth Street,\u00a0Dublin\u00a02,\u00a0Ireland\u00a0on 27 January 2026 at 11.00 a.m.\n(or, if later, as soon as practicable after the Annual General Meeting shall have been concluded or adjourned). The full terms of the Resolutions are set out in the Notice and are summarised below:\n\u2022\nResolution 1, which will be proposed as an ordinary resolution, is to approve the Acquisition for the purposes of Rule 14 of the AIM Rules, subject to the passing of Resolutions 1 above and 3 and 4 below;\n\u2022\nResolution 2, which will be proposed as an ordinary resolution, is to approve the consolidation of the Company's Existing Ordinary Shares into Ordinary Shares of \u20ac0.375 each on the basis of one new ordinary share of \u20ac0.375 each for every 3 Existing Ordinary Shares of \u20ac0.125 each;\n\u2022\nResolution 3, which will be proposed as an ordinary resolution, is to approve, subject to the passing of Resolution 2 above, with effect from 23.59 hours on the date of passing of this resolution, all of the ordinary shares of \u20ac0.375 each in the capital of the Company, whether issued or unissued, be subdivided into one New Ordinary Share of \u20ac0.02 each and three Deferred Shares of \u20ac0.355 each (the \"Deferred Shares\");\n\u2022\nResolution 4, which will be proposed as an ordinary resolution, is to approve, subject to the passing of resolution 2 and 4 above, the increase in the authorised share capital to \u20ac17,500,000;\n\u2022\nResolution 5, which will be proposed as a special resolution, is to approve, subject to the passing of resolution 1 above, the change of the main objects clause of the Company, which will remove all references to all biotech projects;\n\u2022\nResolution 6, which will be proposed as a special resolution, is to approve, subject to the passing of resolution 2, 3 and 4 above, proposed changes to the Memorandum of Association to reflect the changes to the share capital as set out above;\n\u2022\nResolution 7, which will be proposed as a special resolution, is to approve, subject to the passing of resolutions 2,3 and 4 above, the adoption of new Articles, including setting out the new share capital of the Company and the rights attaching to the of the Deferred Shares;\n\u2022\nResolution 8, which will be proposed as a special resolution, is to approve, subject to the passing of resolution 1 above, and the approval of the Registrar of Companies, the change of the name of the Company to Talisman Metals plc; and\n\u2022\nResolution 9, which will be proposed as a special resolution, is to approve, subject to the passing of resolution 1 and 8 above, proposed changes to the Memorandum of Association to reflect the new name and proposed changes to the Articles of Association to reflect the new name.\nAppendix 2\nShare Capital and Placing Statistics\nIssue Price (per Fundraising\nShare)\n7.7p\nNumber of\nExisting\nOrdinary Shares as at the date of this\nDocument\n88,458,805\nNumber of New Ordinary Shares in issue following the Share\nConsolidation\n29,486,268\nNumber of Consideration Shares, Novation Shares and Tadeen Creditor\nShares being issued\n19,688,650\nNumber of Placing\nShares being issued\n4,545,454\nNumber of Subscription\nShares being issued\n10,454,546\nEnlarged\nIssued\nShare Capital on\nAdmission\n64,174,918\nFundraising Shares as a percentage of the Enlarged Share\nCapital\n23.4%\nNumber of Director\nOptions\n3,100,000\nNumber of BCL\nWarrants\n1,298,701\nNumber of Broker Warrants and Introducer Warrants\n392,727\nNumber of Introducer Warrants\n120,000\nFully Dilutive Ordinary Share Capital\nAdmission\n68,693,619\nTotal Dilutive Instruments as a percentage of the fully diluted basis on Admission capital on Admission\n7.0%\nMarket capitalisation of the Company at the Issue Price following\nAdmission\n(1)\n\u00a34.9\nmillion\nGross proceeds of the Fundraising receivable by the\nCompany\n\u00a31.155\nmillion\nEstimated Net Proceeds of the Fundraising receivable by the\nCompany\n(2)\n\u00a30.630\nmillion\nAIM ticker on\nAdmission\nTLM\nISIN for Existing Ordinary\nShares\nIE00B4XVDC01\nISIN in respect of the New Ordinary\nShares\nIE000XRZAWV1\nSEDOL\nBPVD4J9\nLEI\n213800ST2AK5XQ1O5207\nNotes:\n(1)\nThe\nmarket\ncapitalisation\nof\nthe\nGroup\nat\nany\ngiven\ntime\nwill\ndepend\non\nthe\nmarket\nprice\nof\nthe\nShares\nat\nthat\ntime,\nbut\nthis\ncalculation\nis\nbased\nupon\nthe\nIssue\nPrice.\n(2)\nAfter\ndeduction\nof\nestimated\ncommissions,\nfees\nand\nexpenses\npayable\nby\nthe\nCompany\nof\napproximately\n\u00a30.525\nmillion.\nAppendix 3\nExpected Timetable\nPublication of this Admission Document\n30 December 2025\nLatest time and date for receipt of Forms of Proxy for the Extraordinary General\nMeeting\n11.00 a.m. 23 January\n2026\nExtraordinary General\nMeeting\n11.00 a.m. 27 January\n2\n026\n(i)\nRecord Date for the Share Consolidation (the \"Record Date\")\n6.00 p.m. 27 January 2026\nExpected time and date of cancellation of trading on AIM of the Existing Ordinary Shares\n8.00 a.m. 28 January 2026\nExpected time and date of Admission, issue of the New Ordinary Shares and commencement of dealings in the Enlarged Share Capital on AIM\n8.00 a.m 28 January 2026\n(i) Or if later, as soon as practicable after the Annual General Meeting convened for 12.00 p.m. on the same date and at the same place, shall have been concluded or adjourned.\nNote: Each of the dates in the above timetable are subject to change without further notice at the discretion of the Company and the Nomad. All times are UK times unless otherwise stated.\nAppendix 4\nSet out below is the unaudited pro forma statement of net assets of the Enlarged Group as at 30 June 2025 (the \"Pro Forma Financial Information\"). It has been prepared on the basis of the notes below to illustrate the effects of:\n\u2022\nthe acquisition of Tadeen by Ovoca on 30 June\n2025;\n\u2022\nthe issue of the Placing Shares and Subscription Shares;\nand\n\u2022\nthe settlement of the costs\nassociated\non the net assets of Ovoca as if the acquisition of Tadeen, the Placing and [the Subscription] had taken place on 30 June 2025.\nThe Pro Forma Financial Information has been prepared for illustrative purposes only and, because of its nature, will not represent the actual financial position of the Enlarged Group as if the acquisition had taken place on 30 June 2025, or the date of Admission.\n(Unaudited) Ovoca as at 30 June 2025\n(Note 1)\n(Unaudited) Tadeen as at 30 June 2025\n(Note 2)\nAdjustment for the net proceeds from the Placing and Subscription (Note 3)\nAdjustment for the forgiveness of liabilities of Tadeen on the acquisition by Ovoca\nPro forma net assets\n\u20ac'000\n\u20ac'000\n\u20ac'000\n\u20ac'000\n\u20ac'000\nASSETS\nNon-current assets\nAvailable for sale financial assets\n96\n-\n-\n-\n96\nExploration asset -\n-\n478\n-\n-\n478\n96\n478\n-\n-\n574\nCurrent assets\nTrade and other receivables\n39\n-\n-\n-\n39\nCash and cash equivalents\n1,526\n54\n725\n-\n2,305\nTOTAL ASSETS\n1,661\n532\n725\n-\n2918\nLIABILITIES\nCurrent Liabilities\nTrade and other payables\n(186)\n(321)\n-\n296\n(211)\nProvisions\n-\n(2)\n-\n-\n(2)\n(186)\n(323)\n-\n296\n(213)\nNon-current liabilities\nLiabilities included in disposal\ngroup classified as held for sale\n(210)\n-\n-\n-\n(210)\nTOTAL LIABILITIES\n(396)\n(323)\n-\n296\n(423)\nNET ASSETS\n1,265\n209\n725\n296\n2,495\nNotes:\n1.\nThe financial information of Ovoca Bio PLC (\"\nOvoca\n\") as at 30 June 2025 has been extracted from the unaudited interim consolidated financial statements of Ovoca for the period 1 January 2025 to 30 June 2025. No adjustments have been made to these figures to represent trading, expenditure or other movements other than those adjustments represented above.\n2.\nThe financial information of Tadeen International Limited and its subsidiaries (\"\nTadeen\n\") has been extracted from the unaudited interim consolidated financial information of Tadeen as set out in Part 5 of this document.\n3.\nThe adjustment represents expected gross proceeds of \u00a31,155,000 (\u20ac1,316,700) from the Placing and the Subscription, net of readmission costs payable as of 30 June 2025 of \u20ac591,883 with net proceeds being \u20ac724,817. The exchange rates used are those exchange rates used in the pre acquisition cost schedule for consistency. These are as follows:\na.\n\u20ac/$ =\n1.15\nb.\n\u00a3/\u20ac =\n1.14\n4.\nOn execution of the share purchase agreement to acquire Tadeen, the loans from the shareholders of Tadeen will be forgiven in exchange for non-cash consideration.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nMSCDDBDDXUXDGUG",
          "rns_number": "RNS Number : 2066N"
        },
        {
          "title": "Change of Broker",
          "announcement_date": "13th Nov 2025",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "13 Nov 2025 07:00\nRNS Number : 3275H\nOvoca Bio PLC\n13 November 2025\nOvoca Bio PLC\n13 November 2025\nOvoca Bio plc\n(\"Ovoca\" or the \"Company\")\nChange of Broker\nDublin, Ireland, 13 November 2025 - Ovoca Bio Plc announces, in anticipation of completion of the acquisition of Tadeen International Limited as originally announced on 7 May 2025, the appointment of CMC Markets UK Plc, trading as CMC CapX, as broker to the Company with immediate effect. Beaumont Cornish Limited will continue to act as the Company's Nominated Adviser.\nEnd\nFor further information:\nOvoca Bio plc\nTim McCutcheon (Chief Executive Officer)\nTel +353 1 661 9819\ninfo@ovocabio.com\nBeaumont Cornish Limited (Nominated Adviser)\nJames Biddle / Roland Cornish\nTel: +44 (0) 207 628 3396\nCMC Markets UK Plc (Broker)\nDouglas Crippen\nTel: +44 (0) 20 3003 8632\nNominated Adviser Statement\nBeaumont Cornish Limited (\"Beaumont Cornish\"), is the Company's Nominated Adviser and is authorised and regulated in the United Kingdom by the Financial Conduct Authority. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other person for providing the protections afforded to customers of Beaumont Cornish nor for advising them in relation to the transaction and arrangements described in the announcement or any matter referred to in it.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nAPPEAEFAFDESFAA",
          "rns_number": "RNS Number : 3275H"
        },
        {
          "title": "Replacement Half Year Report",
          "announcement_date": "30th Sep 2025",
          "release_time": "1:09 pm",
          "source": "RNS",
          "content": "30 Sep 2025 13:09\nRNS Number : 4541B\nOvoca Bio PLC\n30 September 2025\nThe tables in the \"Half-year Report\" announcement released on 30 September 2025 at 7am under RNS No 3030B were unclear and accordingly the announcement has been updated so that readers can access the tables via a pdf link now contained in the announcement.\nAll other details remain unchanged.\nThe full amended text is shown below.\nOvoca Bio PLC\n30 September 2025\nOvoca Bio plc\n(\"Ovoca\" or the \"Company\")\nInterim Results for the six months ended 30 June 2025\nDublin, Ireland, 30 September 2025 - Ovoca Bio announces its interim financial statements and report covering the six-months ending 30 June 2025.\nPlease click on the following link to view the full Half Year Report and extracts are set out at the end of this announcement:\nhttp://www.rns-pdf.londonstockexchange.com/rns/4541B_1-2025-9-30.pdf\nCEO Statement\nToday we have published Ovoca's financial statements covering the six-month period to the end of June 2025, which I encourage all stakeholders to read. On 7 May 2025 the Company entered into a conditional Letter of Intent (\"LOI\") to acquire 100% of Tadeen International Limited (\"Tadeen\"), a UK-registered company, which indirectly owns 100% of a portfolio of mineral exploration licenses in Morocco prospective for Copper and Silver (the \"Proposed Acquisition\"). The team at Ovoca has been working to complete the Proposed Acquisition and in due course further announcements will be made as we finalize the acquisition of Tadeen.\nAs at 30 June 2025, the Company had cash and cash equivalents amounting to \u20ac1,526 million ($ 1,788 million) and we will continue to carefully manage our financial resources. The costs incurred during the period relate to the costs of work in relation to the Proposed Acquisition along with corporate costs.\nI would like to thank the management team of the Company and the Board of Directors for their support.\nEnd\nFor further information:\nOvoca Bio plc\nTim McCutcheon (Chief Executive Officer)\nTel +353 1 661 9819\ninfo@ovocabio.com\nBeaumont Cornish Limited (Nominated Adviser and Broker)\nJames Biddle/ Roland Cornish\nTel: +44 (0) 207 628 3396\nNominated Adviser Statement\nBeaumont Cornish Limited (\"Beaumont Cornish\"), is the Company's Nominated Adviser and is authorised and regulated in the United Kingdom by the Financial Conduct Authority. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other person for providing the protections afforded to customers of Beaumont Cornish nor for advising them in relation to the transaction and arrangements described in the announcement or any matter referred to in it.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nIR URRURVSUKOAR",
          "rns_number": "RNS Number : 4541B"
        }
      ],
      "themes": [
        "drilling",
        "operations"
      ]
    },
    "social": {
      "has_data": true,
      "buzz_level": "HIGH",
      "post_count": 125,
      "sentiment_breakdown": {
        "positive": 0.0,
        "neutral": 100.0,
        "negative": 0.0
      }
    },
    "trends": {
      "has_data": true,
      "current_interest": 0,
      "momentum_score": 0,
      "trend_direction": "flat",
      "intelligence_signal": "ACCUMULATION"
    },
    "volatility": {
      "atr_normalized": 10.0,
      "stddev_20d": 0.0
    },
    "risk_flags": {
      "split_risk_level": "HIGH",
      "halt_risk": "NONE",
      "penny_stock_risk": "NONE"
    },
    "catalyst_dates": {
      "proxy_date": "2025-01-13"
    }
  },
  "ai_insights": {
    "available": false,
    "reason": "LLM module not loaded or analysis failed"
  },
  "crashdash": {
    "industry_intelligence": {
      "category": "INDUSTRIALS",
      "name": "Industrials",
      "icon": "\ud83c\udfed",
      "color": "#64748b",
      "crash_patterns": [
        "Order book decline or cancellations",
        "Margin compression (input costs)",
        "Cyclical demand weakness",
        "Project delays or overruns",
        "Working capital strain"
      ],
      "recovery_paths": [
        "Order book growth or new contracts",
        "Margin recovery (efficiency gains)",
        "Cyclical upturn (capex recovery)",
        "M&A consolidation",
        "Product innovation or new markets"
      ],
      "active_patterns": [
        "Project delays or overruns"
      ],
      "relevant_rns_count": 0,
      "key_metrics": [
        "Order book value (forward revenue)",
        "Book-to-bill ratio",
        "Operating margin trends",
        "Working capital efficiency",
        "Capex cycles (customer industries)"
      ]
    },
    "panic_analysis": {
      "panic_score": 70,
      "signal": "HIGH_PANIC",
      "interpretation": "\ud83d\udfe0 Fear dominant - watch for reversal signs",
      "breakdown": {
        "price_destruction": 40,
        "volume_death": 14,
        "social_silence": 6,
        "news_sentiment": 10
      },
      "is_opportunity": false,
      "opportunity_reason": "\ud83d\udcca Moderate fear detected - monitor for escalation"
    },
    "fear_vs_facts": {
      "fear_points": [
        "\ud83d\udc94 Price destruction: 40/40 points"
      ],
      "facts_points": [
        "\ud83d\udcc8 Historical upside: 9900% proven capacity",
        "\ud83d\udcb0 Deep value: 28% off recent peak"
      ],
      "verdict": "\u2705 Facts align with low fear - Normal risk/reward"
    },
    "crashhunter_signals": [
      {
        "type": "HIGH_PANIC",
        "icon": "\ud83d\udfe0",
        "text": "Fear 70/100",
        "color": "#f59e0b"
      },
      {
        "type": "BROKEN",
        "icon": "\u274c",
        "text": "Broken",
        "color": "#ef4444"
      },
      {
        "type": "LOW_DATA",
        "icon": "\u2753",
        "text": "Conf 25",
        "color": "#64748b"
      }
    ],
    "catalyst_pipeline": [
      {
        "type": "rns",
        "date": "Unknown",
        "title": "Schedule One - Ovoca Bio Plc",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "Unknown",
        "title": "Notice of AGM",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "Unknown",
        "title": "Publication of Admission Document",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "Unknown",
        "title": "Change of Broker",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "Unknown",
        "title": "Replacement Half Year Report",
        "status": "published",
        "icon": "\ud83d\udce2"
      }
    ],
    "decision_matrix": {
      "decision": "AVOID",
      "reason": "\u274c AVOID - timing BROKEN",
      "checklist": [
        {
          "criterion": "Panic Score",
          "value": "70/100",
          "pass": true,
          "icon": "\ud83d\udd34"
        },
        {
          "criterion": "Timing Regime",
          "value": "BROKEN",
          "pass": false,
          "icon": "\u274c"
        },
        {
          "criterion": "APEX Quality",
          "value": "48/100",
          "pass": false,
          "icon": "\u26a0\ufe0f"
        },
        {
          "criterion": "Data Confidence",
          "value": "25/100",
          "pass": false,
          "icon": "\u2753"
        },
        {
          "criterion": "Industry Pattern",
          "value": "1 active",
          "pass": true,
          "icon": "\ud83c\udfed"
        }
      ],
      "pass_rate": "2/5"
    },
    "contrarian_panic": {
      "total_score": 47,
      "band": "\ud83d\udfe1 MODERATE COMPRESSION (Top 30% - GOOD SETUP)",
      "components": {
        "compression": {
          "score": 7,
          "max": 40,
          "signals_30d": 1,
          "signals_60d": 1,
          "signals_90d": 1,
          "signals_per_week": 0.08,
          "total_signals": 24,
          "rsi_extreme_count": 1,
          "rsi_ultra_count": 1,
          "escalation_count": 0,
          "density_score": 3,
          "rsi_score": 4,
          "escalation_score": 0,
          "description": "0.1 signals/week | 1 RSI<20 | Early stage"
        },
        "intensification": {
          "score": 20,
          "max": 20,
          "recent_types": [
            "CRASH ZONE BOTTOM",
            "EXTREME CRASH BOTTOM",
            "ULTRA CRASH BOTTOM"
          ],
          "escalating": true,
          "sustained": false,
          "current_intensity": 4,
          "pattern": "ESCALATING TO EXTREME - Fear building!"
        },
        "volume_death": {
          "score": 5,
          "max": 15,
          "relative_volume": 2.94,
          "description": "Elevated volume - Some activity"
        },
        "pop_potential": {
          "score": 15,
          "max": 15,
          "best_historical_rally": 9900.0,
          "avg_rally": 509.9,
          "signal_count": 24,
          "description": "MONSTER POPPER - Historical 10x+ (9900%)"
        },
        "accumulation": {
          "score": 0,
          "max": 10,
          "has_accumulation": false,
          "bars_since_accum": 0,
          "description": "No accumulation"
        }
      },
      "ticker": "OVB.L",
      "signal_date": "2025-01-10",
      "total_signals_history": 24
    }
  },
  "scoring_breakdown": {
    "apex_factors": [
      "Technical quality: +18 (AI_Technical_Score=14.0/20)",
      "Drawdown reversion potential: +20 (Drawdown_Pct=99.2%)",
      "Volume confirmation: +10 (Relative_Volume=2.9)",
      "Pattern reliability: +5 (Rally_Count=1.0)",
      "Upside history: +20 (best_rally_pct=9900%)",
      "Split risk penalty: -15 (HIGH, age_factor=1.00)",
      "Recent exhaustion: -10 (best_rally=9900%, days_since_high=8.0)"
    ],
    "technical_score": {
      "points": 18,
      "ai_score": 14.0,
      "reason": "AI Technical Score 14.0/20 translates to 18/25 points"
    },
    "drawdown_score": {
      "points": 20,
      "drawdown_pct": 99.19,
      "reason": "Drawdown of 99.2% gives 20/20 points"
    },
    "volume_score": {
      "points": 10,
      "rel_volume": 2.94,
      "reason": "Relative volume 2.94x gives 10 points"
    },
    "pattern_score": {
      "points": 5,
      "rally_count": 1.0,
      "reason": "1.0 historical rallies gives 5/15 points"
    },
    "upside_score": {
      "points": 20,
      "best_rally_pct": 9900.0,
      "reason": "Best rally of 9900% gives 20/20 points"
    },
    "penalties": {
      "total": -25,
      "items": [
        "Split risk penalty: -15 (HIGH, age_factor=1.00)",
        "Recent exhaustion: -10 (best_rally=9900%, days_since_high=8.0)"
      ]
    }
  },
  "reasons_buy_sell": {
    "reasons_to_buy": [
      {
        "reason": "Historically strong runner - massive upside when it moves",
        "tag": "HIGH",
        "evidence": [
          "best_rally_pct=9900%",
          "Rally_Count=1.0"
        ]
      },
      {
        "reason": "Proven winner - previously hit lock-in target",
        "tag": "MED",
        "evidence": [
          "lock_in_reached=True"
        ]
      }
    ],
    "reasons_to_sell": [
      {
        "reason": "Split risk HIGH - price integrity compromised",
        "tag": "HIGH",
        "evidence": [
          "split_risk_level=HIGH"
        ]
      },
      {
        "reason": "Stale signal - not for active trading",
        "tag": "HIGH",
        "evidence": [
          "status=historical",
          "signal_date=2025-01-10"
        ]
      }
    ]
  },
  "trade_plan": {
    "trader_plan": {
      "style": "Avoid",
      "action": "Do not trade - thesis invalidated",
      "sizing": "0%",
      "risk": "N/A",
      "profit_taking": "N/A"
    },
    "investor_plan": {
      "allowed": false,
      "thesis_conditions": "Unlock after AI triangulation + CONFIRMED timing",
      "hold_window": "N/A",
      "risk_management": "N/A"
    }
  },
  "exhaustion": {
    "regime": "BROKEN",
    "run_multiple": -0.0,
    "current_run_pct": -28.12,
    "avg_historical_run_pct": 9900.0
  },
  "history_snapshot": {
    "previous_report_date": null,
    "score_change": null,
    "confidence_change": null,
    "new_events_count": 0,
    "new_rns_titles": []
  },
  "commentary": {
    "executive_summary": "This report runs in HISTORICAL-ONLY mode: triangulation (RNS/social/trends) not loaded. The setup shows BROKEN timing with 48/100 APEX score. Historical data shows 1 rallies averaging 9900% upside. Current position: -28.1%. Your edge comes from waiting for AI Engine confirmation instead of blind entry.",
    "bull_case": [
      "Strong historical rally behavior (9900% best run)"
    ],
    "bear_case": [
      "Monitor for breakdown signals"
    ],
    "timing_translation": "Thesis invalidated. Avoid or exit.",
    "confidence_explained": "Confidence 25/100 reflects full data quality with triangulation loaded."
  },
  "data_quality": {
    "sources_present": {
      "snapshot_json": false,
      "daily_enrichment_row": true,
      "historical_profile": true,
      "metadata": true,
      "triangulation_events": true,
      "ai_insights": false
    },
    "missing_data": [
      "AI insights from Groq LLM"
    ],
    "confidence_impact": "HIGH",
    "disclaimer": "Data provided as-is. Not financial advice. AIM micro-caps carry significant volatility risk."
  }
}